Latest Form 4 insider transactions

OQB
Henry J Leader, a Director of Gouverneur Bancorp, Inc./MD/, reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Jay A Snowden, a Director of Wingstop Inc., received 965 shares of common stock on August 6, 2026.
NASDAQ
Daniel P. Govin, Chief Operating Officer (COO) of Sterling Infrastructure, Inc., reported a transaction in 6,559 shares of common stock on August 6, 2026.
NASDAQ
Trump Media & Technology Group reported a $238.1 million net loss for Q2 2026, alongside revenue growth and the launch of a new data licensing product, while advancing its proposed merger with TAE Technologies.
NASDAQ
Amit Agarwal, a Director of Datadog, Inc., sold 20,000 shares of common stock on August 6, 2026.
NASDAQ
Cyclerion Therapeutics announces progress on its merger with Korsana Biosciences, detailing forward-looking statements and regulatory filings.
NASDAQ
Daniel Swayze, Chief Operating Officer of Bowman Consulting Group Ltd., sold 914 shares of common stock on August 7, 2026 for $27.24 per share.
NYSE
Robert Sean Collins, Vice President and Controller of Crown Castle Inc., sold 1,500 shares of common stock on August 7, 2026 for $75.89 per share.
NYSE
Beth Ferreira, President, Diversified Indstrl of DuPont de Nemours, Inc., reported a transaction in 374 shares of common stock on August 6, 2026.
NYSE
Corre Partners Management, LLC and 3 others reported changes in beneficial ownership of Team Inc common stock on August 6, 2026.
NYSE
James Whitehead, a Director of Black Stone Minerals, L.P., sold 2,127,105 shares of common stock on August 6, 2026 for $13.21 per share.
NASDAQ
Francis E Felber, a Director of Citizens Community Bancorp Inc., purchased 500 shares of common stock on August 10, 2026 for $20.25 per share.
NYSE
Madeleine G Barber, VP Chief Accounting Officer of DuPont de Nemours, Inc., reported a transaction in 101 shares of common stock on August 6, 2026.
NYSE
M Terry Turner, a Director of Pinnacle Financial Partners, Inc., sold 2,737 shares of common stock on August 6, 2026 for $108.01 per share.
NYSE
Matthew Wall, See Remarks of Kinetik Holdings Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Trevor Howard, See Remarks of Kinetik Holdings Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Kenneth L. Cornick, a Director of Clarivate Plc, purchased 900,000 shares of common stock on August 6, 2026.
NYSE
Lindsay Ellis, See Remarks of Kinetik Holdings Inc., reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Ned N. Fleming Iv, Senior VP - Strategy & Bus Dev of Construction Partners, Inc., received 50,000 shares of common stock on August 6, 2026.
NYSE
Steven Stellato, See Remarks of Kinetik Holdings Inc., reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Gregory A Hoffman, SVP, Chief Financial Officer of Construction Partners, Inc., received 50,000 shares of common stock on August 6, 2026.
NASDAQ
Judson Ryan Brooks, SVP and General Counsel of Construction Partners, Inc., received 40,000 shares of common stock on August 6, 2026.
NASDAQ
Robert G Baugnon, Senior VP, Personnel and Admin of Construction Partners, Inc., received 40,000 shares of common stock on August 6, 2026.
NYSE
Michael Edward Regan, a Director of Provident Financial Services Inc, received 3,066 shares of common stock on August 7, 2026.
NYSE
Michael David Stewart, a Director and 10% owner of Team Inc, purchased 1,604,326 shares of common stock on August 6, 2026.
NYSE
Robert Brian Mitchell, EVP, General Counsel and CRO of Globe Life Inc., sold 23,000 shares of common stock on August 7, 2026.
NASDAQ
Stephen M Bianchi, CEO and President and a Director of Citizens Community Bancorp Inc., purchased 1,000 shares of common stock on August 10, 2026 for $20.50 per share.
NYSE
Michael Gunnar Knell, SVP, Finance and CAO of Charles River Laboratories International, Inc., sold 6,645 shares of common stock on August 6, 2026.
NYSE
Fernando Machado, Chief Brand Officer of Chipotle Mexican Grill Inc, reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 7, 2026.